The growing demand for treatment options of complex coronary artery lesions, CAD is fueling the growth of the global drug-coated balloons market.
Arizton’s recent market research report on the global DCB market identifies Medtronic, BD, B. Braun Melsungen, and Koninklijke Philips as the leading vendors that are likely to dominate the market during the forecast period. This research report provides a detailed analysis of marketsegmentation by indication (DCB for peripheral artery disease, DCB for coronary artery disease, and DCB for other indications), by end-user (hospitals, cardiac catheterization labs, and ASCs), and by geography (North America, Europe, APAC, and ROW).
The global DCB market is anticipated to generate revenues of more than $1 billion by 2024, growing at a CAGR of around 17% during 2018-2024.
The global DCB market is divided into three major segments that consist of indication, end-users, and geography.
DCB for coronary artery disease to grow at a considerable CAGR in the global DCB market during the forecast period
The global DCB market by indications is divided into DCB for peripheral artery disease, DCB for coronary artery disease, and DCB for other indications. Drug-coated balloons for coronary artery disease (CAD) segment dominated less than 1/3rd of the total market share in 2018, growing at a CAGR of around 16% during the forecast period. The growing demand for treatment options of complex coronary artery lesions, such as small-vessel disease and long diffuse CAD is fueling the growth of this segment in the global market. The development of drug-coated balloons technology is a viable alternative treatment option for the inhibition of coronary restenosis and subsequent revascularization in patients with CAD, thereby, fueling the demand in the global DCB market. Many vascular surgeons believe that these procedures are superior and cost-effective than treating CAD with DES in the long-term in the market. The surgeons are also considering this procedure as an innovative therapeutic option in interventional cardiology. Drug-coated balloons catheters deliver the anti-proliferative drug to the target arterial, as well as prevent restenosis without the need for additional implants like stents; their usage has expanded in treating coronary artery lesions. The vendors are offering innovative devices to attract the maximum number of consumers in the global DCB market.
Hospital segment to grow at a significant CAGR in the global DCB market during the forecast period
The end-user segment in the global DCB market is categorized into hospitals, cardiac catheterization labs, and ASCs. Hospitals segment occupied more than half of the total market share in 2018, growing at a CAGR of over 16% during the forecast period. The growing demand for highly advanced and innovative catheter-based cardiovascular and endovascular procedures will boost the adoption of drug-coated balloons across hospitals. Hospitals in developed countries such as the US, Germany, France, and Japan are adopting these procedures. These angioplasty procedures for treating a broad range of high-risk and complicated vascular diseases are gaining immense popularity among renowned hospitals, resulting in higher revenues in the global DCB market. The leading government hospitals are inviting tenders as per their need and requirement based on patient volume and demand in the market. The vendors are also offering discounts on bulk purchases by large hospitals to boost the adoption of these procedures. The players are focusing on profitability, patient benefits, and handling charges to increase their revenues across the hospital segment in the global DCB market.
Europe to grow at an impressive CAGR in the global DCB market during the forecast period
The global DCB market by geography is segmented into North America, Europe, APAC, and ROW. Europe dominated more than 1/3rd of the total market share in 2018, growing at a CAGR of approximately 17% during the forecast period. The growing demand for MI endovascular procedures, changes in lifestyle patterns of people, rising geriatric population, and increasing prevalence of vascular diseases are some of the factors attributing to the growth of the European region in the global market. The development of sophisticated and established healthcare infrastructure and advanced services across Western Europe will contribute to the development of the European region in the global DCB market. The availability of a diverse range of procedures for various ailments like PAD, CAD, AVF, and AVG will create lucrative opportunities for leading vendors operating in the European market. Clinical trials and patent approvals for European vendors will lead to the development of the global DCB market.
The other prominent players operating in the global DCB market are Boston Scientific, Opto Circuits (India), Acotec Scientific, AR Baltic Medical, Acrostak, Biosensors International Group,Cardionovum, Endocor, iVascular SLU, Minvasys, QT Vascular, BioMed ,SurModics, Concept Medical, Hexacath Sverige, RD Global-Invamed, MedAlliance, Terumo, and Wellinq.
The complete overview of the latest market research report on the global DCB market by Arizton is now available.
The report also offers a detailed study of major trends, drivers, challenges, and also provides the market size and forecast for major geographical regions and key countries.
Arizton – Advisory and Intelligence is an innovation and quality-driven firm, which offers cutting-edge research solutions to clients across the world. We excel in providing comprehensive market intelligence reports and advisory and consulting services.
We offer comprehensive market research reports on industries such as consumer goods & retail technology, automotive and mobility, smart tech, healthcare, and life sciences, industrial machinery, chemicals and materials, IT and media, logistics and packaging. These reports contain detailed industry analysis, market size, share, growth drivers, and trend forecasts.
Arizton comprises a team of exuberant and well-experienced analysts who have mastered in generating incisive reports. Our specialist analysts possess exemplary skills in market research. We train our team in advanced research practices, techniques, and ethics to outperform in fabricating impregnable research reports.
+1 302 469 0707